| Website | augmenta.se/index... |
| Employees | |
| Description | private equity |
Augmenta will invest in early stages of companies with unique products and strong growth potential.
When portfolio companies have a fully developed product or service that is ready for commercialization, will Augmenta to leave their interests in portfolio companies. Exactly when this will happen will vary and depend on each company’s unique situation.
| Company | Date | Round | Size | Participants |
| Adenovir Pharma | 6/10 | Venture Round | $787k | 5 |